Bencich John has filed 19 insider transactions across 2 companies since January 2023.
Most recent transaction: a grant/award of 754717 shares of AEON Biopharma, Inc. ($AEON) on April 02, 2026.
Activity breakdown: 3 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 2, 2026 | AEON Biopharma, Inc. | $AEON | Bencich John | CHIEF FINANCIAL OFFICER | A | Class A Common Stock | 754717 | $0.00 | 754,717.0000 | 11,634,946 | 9999.99% | 6.49% |
| Aug. 16, 2024 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | A | Common Stock | 5000 | $3.67 | 100,636.0000 | 0 | 5.23% | 0.00% |
| April 19, 2024 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | F | Common Stock | 6088 | $4.51 | 95,636.0000 | 0 | 5.98% | 0.00% |
| April 19, 2024 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | M | Performance Restricted Stock Unit (PRSU) | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 19, 2024 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | M | Common Stock | 25000 | $0.00 | 101,724.0000 | 0 | 32.58% | 0.00% |
| March 4, 2024 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | P | Common Stock Warrants (right to buy) | 10000 | $0.00 | 10,000.0000 | 0 | 9999.99% | 0.00% |
| March 4, 2024 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | P | Common Stock | 10000 | $4.59 | 76,724.0000 | 0 | 14.99% | 0.00% |
| Jan. 22, 2024 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | A | Stock Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 22, 2024 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | A | Performance Restricted Stock Unit (PRSU) | 175000 | $0.00 | 175,000.0000 | 0 | 9999.99% | 0.00% |
| May 30, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | P | Common Stock | 5000 | $5.50 | 66,730.0000 | 0 | 8.10% | 0.00% |
| April 28, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | F | Common Stock | 1827 | $8.29 | 61,730.0000 | 0 | 2.87% | 0.00% |
| April 28, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | M | Performance Restricted Stock Unit (PRSU) | 7500 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| April 28, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | M | Common Stock | 7500 | $0.00 | 63,557.0000 | 0 | 13.38% | 0.00% |
| April 21, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | F | Common Stock | 5863 | $6.80 | 56,057.0000 | 0 | 9.47% | 0.00% |
| April 21, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | M | Common Stock | 25000 | $0.00 | 61,920.0000 | 0 | 67.71% | 0.00% |
| April 21, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | F | Common Stock | 7324 | $6.80 | 54,596.0000 | 0 | 11.83% | 0.00% |
| April 21, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | M | Performance Restricted Stock Unit (PRSU) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 25, 2023 | ACHIEVE LIFE SCIENCES, INC. | $ACHV | Bencich John | CEO | A | Performance Restricted Stock Unit (PRSU) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |